Prashanth Suravajhala Selected Research

Prashanth Suravajhala Research Topics

6	Neoplasms (Cancer) 04/2024 - 01/2013
4	COVID-19 10/2023 - 01/2021
4	Anorectal Malformations 05/2023 - 01/2018
3	Dehydration (Water Stress) 01/2020 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 12/2021
2	Infections 10/2023 - 01/2022
1	Obesity 12/2023
1	Mpox (monkeypox) 06/2023
1	Zoonoses 06/2023
1	Scrub Typhus (Typhus, Scrub) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 12/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Insulin Resistance 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Mycoses (Diseases, Fungus) 01/2016
1	Brucellosis (Malta Fever) 06/2015

5	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2015
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 05/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 06/2015
2	Long Noncoding RNAIBA 01/2022 - 10/2021
2	ProteomeIBA 12/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2023
1	Immunoglobulin M (IgM)IBA 10/2023
1	Immunoglobulin G (IgG)IBA 10/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 06/2023
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2023
1	Mitochondrial Permeability Transition PoreIBA 01/2023
1	AntigensIBA 01/2023
1	FlavonoidsIBA 10/2022
1	QuercetinIBA 10/2022
1	tamarixetinIBA 10/2022
1	Viral ProteinsIBA 10/2021
1	CurcuminIBA 01/2021
1	LipidsIBA 01/2018
1	ElementsIBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	AflatoxinsIBA 01/2016
1	VaccinesIBA 06/2015
1	MicroRNAs (MicroRNA)IBA 01/2013

1	Immunotherapy 04/2024
1	Therapeutics 04/2024